SEC Info - Evolent Health, Inc. - ‘8-K’ for 11/5/20

SEC Info℠

Home

Help

Please Sign In

Evolent Health, Inc. – ‘8-K’ for 11/5/20

On: Thursday, 11/5/20, at 4:25pm ET · For: 11/5/20 · Accession #: 1628908-20-137 · File #: 1-37415

  As Of               Filer                 Filing    For·On·As Docs:Size

11/05/20  Evolent Health, Inc.              8-K:2,9    11/05/20   13:951K

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     28K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    203K 
 9: R1          Cover Page Cover Page                               HTML     48K 
11: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- evh-20201105_htm                    XML     23K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.CAL  XBRL Calculations -- evh-20201105_cal                XML      7K 
 5: EX-101.DEF  XBRL Definitions -- evh-20201105_def                 XML     39K 
 6: EX-101.LAB  XBRL Labels -- evh-20201105_lab                      XML     81K 
 7: EX-101.PRE  XBRL Presentations -- evh-20201105_pre               XML     40K 
 3: EX-101.SCH  XBRL Schema -- evh-20201105                          XSD     11K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    20K 
13: ZIP         XBRL Zipped Folder -- 0001628908-20-000137-xbrl      Zip     42K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C:

evh-20201105

i November 5, 2020 i 0001628908 i false00016289082020-11-052020-11-05


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

_________________________

FORM i 8-K

_________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

i November 5, 2020

Date of Report (Date of earliest event reported)

i Evolent Health, Inc.

(Exact name of registrant as specified in its charter)

_________________________

i Delaware

i 001-37415

i 32-0454912

(State or other jurisdiction of
incorporation or organization)

Commission File Number:

(I.R.S. Employer
Identification No.)

i 800 N. Glebe Road

i Suite 500

i Arlington

i Virginia

i 22203

(Address of principal executive offices)(zip code)

( i 571) i 389-6000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report.)

_________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Class A Common Stock of Evolent Health, Inc., par value $0.01 per share	i EVH	i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition

On November 5, 2020, Evolent Health, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2020, a copy of which is furnished herewith as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

The following exhibits are being furnished with this Form 8-K.


Exhibit
Number						Description
99.1						Press release dated November 5, 2020, announcing Evolent Health, Inc.'s financial results for the quarter ended September 30, 2020

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


EVOLENT HEALTH, INC.

By:			/s/ *Aammaad Shams*
Name:			Aammaad Shams
Title:			Controller


By:			/s/ *Jonathan Weinberg*
Name:			Jonathan Weinberg
Title:			General Counsel and Secretary

Dated: November 5, 2020

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on / For Period end:	11/5/20	10-Q
	9/30/20	10-Q
		List all Filings

↑Top

Filing Submission 0001628908-20-000137 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Evolent Health, Inc. – ‘8-K’ for 11/5/20

On: Thursday, 11/5/20, at 4:25pm ET · For: 11/5/20 · Accession #: 1628908-20-137 · File #: 1-37415

Previous ‘8-K’: ‘8-K’ on / for 9/29/20 · Next: ‘8-K’ on 12/14/20 for 12/10/20 · Latest: ‘8-K’ on / for 2/22/24

Current Report — Form 8-KFiling Table of Contents

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Current Report — Form 8-K
Filing Table of Contents